Cogent Biosciences (COGT) EPS (Basic): 2017-2020
Historic EPS (Basic) for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$16.17.
- Cogent Biosciences' EPS (Basic) fell 12400.00% to -$8.61 in Q4 2020 from the same period last year, while for Dec 2020 it was -$15.44, marking a year-over-year decrease of 595.50%. This contributed to the annual value of -$16.17 for FY2020, which is 286.84% down from last year.
- Per Cogent Biosciences' latest filing, its EPS (Basic) stood at -$16.17 for FY2020, which was down 286.84% from -$4.18 recorded in FY2019.
- Cogent Biosciences' 5-year EPS (Basic) high stood at -$1.39 for FY2018, and its period low was -$16.17 during FY2020.
- Moreover, its 3-year median value for EPS (Basic) was -$4.18 (2019), whereas its average is -$7.25.
- Its EPS (Basic) has fluctuated over the past 5 years, first skyrocketed by 44.62% in 2018, then crashed by 286.84% in 2020.
- Cogent Biosciences' EPS (Basic) (Yearly) stood at -$2.51 in 2017, then surged by 44.62% to -$1.39 in 2018, then plummeted by 200.72% to -$4.18 in 2019, then plummeted by 286.84% to -$16.17 in 2020.